Dr Daniel Hodson

Dr Hodson is a Medical Research Council (MRC) Clinician Scientist Fellow and Principal Investigator in the Cambridge Stem Cell Institute (SCI) and Department of Hematology. His group researches the molecular mechanisms that underlie lymphomagenesis. He also holds an honorary consultant contract in the Hematology Department at Addenbrooke’s Hospital.

Dr Hodson studied Medicine at Cambridge University, then clinical medicine at Oxford University, and subsequently trained as a clinical hematologist with a special interest in lymphoid malignancies. During this hematology training he completed a PhD in molecular immunology at the Babraham Institute in Cambridge. In 2010 he moved to the National Cancer Institute, USA, as a post-doctoral fellow, where he developed expertise in the application of functional genomics to the study of B cell lymphomas, before returning to Cambridge in 2015 to take up his current roles.